复星万邦（江苏）医药集团有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
70
NMPA:70
Drug Approvals
Sildenafil Citrate Tablets
- Product Name
- 枸橼酸西地那非片
- Approval Number
- 国药准字H20254408
- Approval Date
- Jun 3, 2025
NMPA
Sildenafil Citrate Tablets
- Product Name
- 枸橼酸西地那非片
- Approval Number
- 国药准字H20254409
- Approval Date
- Jun 3, 2025
NMPA
Avatrombopag Maleate Tablets
- Product Name
- 马来酸阿伐曲泊帕片
- Approval Number
- 国药准字H20254261
- Approval Date
- May 27, 2025
NMPA
Mixed Protamine Human Insulin Injection(30R)
- Product Name
- 万邦林
- Approval Number
- 国药准字S20093036
- Approval Date
- Oct 22, 2024
NMPA
Parecoxib Sodium for Injection
- Product Name
- 注射用帕瑞昔布钠
- Approval Number
- 国药准字H20193293
- Approval Date
- Sep 10, 2024
NMPA
Parecoxib Sodium for Injection
- Product Name
- 注射用帕瑞昔布钠
- Approval Number
- 国药准字H20193292
- Approval Date
- Sep 10, 2024
NMPA
Mixed Protamine Zinc Insulin Lispro Injection(50R)
- Product Name
- 精蛋白锌赖脯胰岛素混合注射液(50R)
- Approval Number
- 国药准字S20240019
- Approval Date
- May 21, 2024
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- Next
Clinical Trials
No trials found
News
No news found